nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromfenac—PTGS2—periodontitis	0.974	1	CbGaD
Bromfenac—PTGS2—periosteum—periodontitis	0.00395	0.34	CbGeAlD
Bromfenac—Tolmetin—CXCL8—periodontitis	0.00194	0.147	CrCbGaD
Bromfenac—Indomethacin—PPARA—periodontitis	0.00171	0.129	CrCbGaD
Bromfenac—PTGS1—endothelium—periodontitis	0.00152	0.131	CbGeAlD
Bromfenac—Tolmetin—MPO—periodontitis	0.00151	0.114	CrCbGaD
Bromfenac—PTGS2—endothelium—periodontitis	0.00146	0.125	CbGeAlD
Bromfenac—Indomethacin—CXCL8—periodontitis	0.00119	0.0894	CrCbGaD
Bromfenac—PTGS2—mouth—periodontitis	0.00112	0.0966	CbGeAlD
Bromfenac—Diclofenac—CXCL8—periodontitis	0.00107	0.0807	CrCbGaD
Bromfenac—Ketoprofen—CXCL8—periodontitis	0.000948	0.0715	CrCbGaD
Bromfenac—PTGS2—trigeminal ganglion—periodontitis	0.000829	0.0713	CbGeAlD
Bromfenac—Balsalazide—PTGS2—periodontitis	0.000785	0.0592	CrCbGaD
Bromfenac—PTGS1—connective tissue—periodontitis	0.00072	0.0619	CbGeAlD
Bromfenac—Lumiracoxib—PTGS2—periodontitis	0.000718	0.0541	CrCbGaD
Bromfenac—PTGS2—connective tissue—periodontitis	0.000688	0.0592	CbGeAlD
Bromfenac—PTGS1—epithelium—periodontitis	0.000684	0.0588	CbGeAlD
Bromfenac—Nepafenac—PTGS2—periodontitis	0.000683	0.0515	CrCbGaD
Bromfenac—PTGS2—epithelium—periodontitis	0.000653	0.0562	CbGeAlD
Bromfenac—Fenbufen—PTGS2—periodontitis	0.000653	0.0492	CrCbGaD
Bromfenac—Tolmetin—PTGS2—periodontitis	0.000567	0.0428	CrCbGaD
Bromfenac—Suprofen—PTGS2—periodontitis	0.000544	0.041	CrCbGaD
Bromfenac—Indomethacin—PTGS2—periodontitis	0.000346	0.0261	CrCbGaD
Bromfenac—Diclofenac—PTGS2—periodontitis	0.000312	0.0236	CrCbGaD
Bromfenac—Ketoprofen—PTGS2—periodontitis	0.000277	0.0209	CrCbGaD
Bromfenac—PTGS1—Eicosanoid Synthesis—GGT1—periodontitis	4.08e-05	0.0486	CbGpPWpGaD
Bromfenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC52A3—periodontitis	3.53e-05	0.042	CbGpPWpGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—CRP—periodontitis	3.42e-05	0.0407	CbGpPWpGaD
Bromfenac—PTGS2—Eicosanoid Synthesis—GGT1—periodontitis	3.24e-05	0.0386	CbGpPWpGaD
Bromfenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—periodontitis	3.15e-05	0.0375	CbGpPWpGaD
Bromfenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—periodontitis	2.92e-05	0.0348	CbGpPWpGaD
Bromfenac—PTGS2—Overview of nanoparticle effects—CRP—periodontitis	2.71e-05	0.0323	CbGpPWpGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—PTGS2—periodontitis	2.29e-05	0.0273	CbGpPWpGaD
Bromfenac—PTGS1—Arachidonic acid metabolism—GGT1—periodontitis	2.27e-05	0.027	CbGpPWpGaD
Bromfenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—periodontitis	2.24e-05	0.0267	CbGpPWpGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—CXCL8—periodontitis	2.22e-05	0.0265	CbGpPWpGaD
Bromfenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—periodontitis	2.08e-05	0.0248	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—MPO—periodontitis	1.9e-05	0.0227	CbGpPWpGaD
Bromfenac—PTGS1—Eicosanoid Synthesis—PTGS2—periodontitis	1.9e-05	0.0226	CbGpPWpGaD
Bromfenac—PTGS2—Arachidonic acid metabolism—GGT1—periodontitis	1.8e-05	0.0215	CbGpPWpGaD
Bromfenac—PTGS2—Overview of nanoparticle effects—CXCL8—periodontitis	1.76e-05	0.021	CbGpPWpGaD
Bromfenac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—periodontitis	1.59e-05	0.0189	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—MPO—periodontitis	1.57e-05	0.0187	CbGpPWpGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—TNF—periodontitis	1.55e-05	0.0184	CbGpPWpGaD
Bromfenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—periodontitis	1.52e-05	0.0181	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—MPO—periodontitis	1.51e-05	0.018	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—periodontitis	1.45e-05	0.0172	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—GGT1—periodontitis	1.44e-05	0.0172	CbGpPWpGaD
Bromfenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—periodontitis	1.35e-05	0.0161	CbGpPWpGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—IL6—periodontitis	1.25e-05	0.0149	CbGpPWpGaD
Bromfenac—PTGS2—Overview of nanoparticle effects—TNF—periodontitis	1.23e-05	0.0146	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—FCGR2A—periodontitis	1.21e-05	0.0144	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—GGT1—periodontitis	1.15e-05	0.0137	CbGpPWpGaD
Bromfenac—PTGS1—Arachidonic acid metabolism—PTGS2—periodontitis	1.06e-05	0.0126	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—CCR2—periodontitis	1.05e-05	0.0125	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—CRP—periodontitis	1e-05	0.0119	CbGpPWpGaD
Bromfenac—PTGS2—Overview of nanoparticle effects—IL6—periodontitis	9.9e-06	0.0118	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—periodontitis	8.74e-06	0.0104	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—GGT1—periodontitis	8.45e-06	0.0101	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—CCL2—periodontitis	8.24e-06	0.00982	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—periodontitis	8.13e-06	0.00969	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—CRP—periodontitis	7.95e-06	0.00948	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—IL1A—periodontitis	7.52e-06	0.00897	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—IL4—periodontitis	7.28e-06	0.00867	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—IFNG—periodontitis	7.01e-06	0.00835	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—PTGS2—periodontitis	6.72e-06	0.00801	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—CCL2—periodontitis	6.54e-06	0.0078	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—IL1B—periodontitis	6.25e-06	0.00745	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—periodontitis	6.05e-06	0.00721	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—TLR4—periodontitis	6.03e-06	0.00719	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	5.82e-06	0.00694	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—NOS2—periodontitis	5.74e-06	0.00684	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—periodontitis	5.66e-06	0.00674	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—IFNG—periodontitis	5.56e-06	0.00663	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—CCL2—periodontitis	5.17e-06	0.00617	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—IL1B—periodontitis	4.96e-06	0.00591	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—TNF—periodontitis	4.54e-06	0.0054	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—SLC52A3—periodontitis	4.41e-06	0.00525	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—IFNG—periodontitis	4.4e-06	0.00524	CbGpPWpGaD
Bromfenac—PTGS2—Disease—SLC52A3—periodontitis	4.18e-06	0.00498	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—CXCL8—periodontitis	4.09e-06	0.00487	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—IL1B—periodontitis	3.92e-06	0.00468	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—MMP9—periodontitis	3.7e-06	0.00441	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—IL6—periodontitis	3.66e-06	0.00436	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—TNF—periodontitis	3.6e-06	0.00429	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—SLC52A3—periodontitis	3.5e-06	0.00417	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—GGT1—periodontitis	3.24e-06	0.00386	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	3.18e-06	0.00379	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—TGFB1—periodontitis	3.05e-06	0.00363	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—IL6—periodontitis	2.91e-06	0.00346	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—TNF—periodontitis	2.85e-06	0.00339	CbGpPWpGaD
Bromfenac—PTGS2—Disease—LTF—periodontitis	2.84e-06	0.00338	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ACP5—periodontitis	2.6e-06	0.00309	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	2.57e-06	0.00307	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ACP5—periodontitis	2.46e-06	0.00293	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	2.32e-06	0.00277	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—IL6—periodontitis	2.3e-06	0.00274	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	2.07e-06	0.00247	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ACP5—periodontitis	2.06e-06	0.00246	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	1.94e-06	0.00231	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	1.84e-06	0.0022	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	1.51e-06	0.0018	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GGT1—periodontitis	1.44e-06	0.00172	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GGT1—periodontitis	1.15e-06	0.00137	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PPARA—periodontitis	1.03e-06	0.00123	CbGpPWpGaD
Bromfenac—PTGS2—Disease—NOS2—periodontitis	8.66e-07	0.00103	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PPARA—periodontitis	8.21e-07	0.000978	CbGpPWpGaD
Bromfenac—PTGS2—Disease—FGF2—periodontitis	7.06e-07	0.000842	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PTGS2—periodontitis	6.72e-07	0.000801	CbGpPWpGaD
Bromfenac—PTGS2—Disease—TGFB1—periodontitis	4.61e-07	0.000549	CbGpPWpGaD
Bromfenac—PTGS2—Disease—IL6—periodontitis	3.47e-07	0.000414	CbGpPWpGaD
